Sonnet BioTherapeutics
SONN
SONN
10 hedge funds and large institutions have $110K invested in Sonnet BioTherapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 15 closing their positions.
Holders
10
Holders Change
-13
Holders Change %
-56.52%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
2
Reduced
6
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$10.6K |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$270 |
| 3 |
3
Citigroup
New York
|
$9 |
| 4 |
IA
4
IFP Advisors
Tampa,
Florida
|
$45 |
